Portola Pharmaceuticals, Inc. EBITDA 2013-2020 | PTLA
Portola Pharmaceuticals, Inc. ebitda from 2013 to 2020. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Portola Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2019 | $-266 |
| 2018 | $-344 |
| 2017 | $-271 |
| 2016 | $-267 |
| 2015 | $-223 |
| 2014 | $-132 |
| 2013 | $-80 |
| 2012 | $14 |
| 2011 | $22 |
| 2010 | $-17 |
| Portola Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2020-03-31 | $-58 |
| 2019-12-31 | $-90 |
| 2019-09-30 | $-43 |
| 2019-06-30 | $-60 |
| 2019-03-31 | $-73 |
| 2018-12-31 | $-87 |
| 2018-09-30 | $-69 |
| 2018-06-30 | $-103 |
| 2018-03-31 | $-85 |
| 2017-12-31 | $-86 |
| 2017-09-30 | $-80 |
| 2017-06-30 | $-65 |
| 2017-03-31 | $-40 |
| 2016-12-31 | $-55 |
| 2016-09-30 | $-91 |
| 2016-06-30 | $-57 |
| 2016-03-31 | $-64 |
| 2015-12-31 | $-65 |
| 2015-09-30 | $-55 |
| 2015-06-30 | $-58 |
| 2015-03-31 | $-45 |
| 2014-12-31 | $-38 |
| 2014-09-30 | $-35 |
| 2014-06-30 | $-30 |
| 2014-03-31 | $-30 |
| 2013-12-31 | $-24 |
| 2013-09-30 | $-18 |
| 2013-06-30 | $-21 |
| 2013-03-31 | $-17 |
| 2012-09-30 | $-11 |
| 2012-06-30 | $51 |
